Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.
Lindmark F, Zheng SL, Wiklund F, Bälter KA, Sun J, Chang B, Hedelin M, Clark J, Johansson JE, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J.
Lindmark F, et al. Among authors: balter ka.
Br J Cancer. 2005 Aug 22;93(4):493-7. doi: 10.1038/sj.bjc.6602729.
Br J Cancer. 2005.
PMID: 16106254
Free PMC article.